Effect of daclizumab (Zenapax) on prevention of acute rejection of renal transplantation

Author： Poorrezagholi F.   Einollahi B.   Firoozan A.   Nafar M.   Yadegari H.   Moghaddam S.M.M.H.   Simforoosh N.   Basiri A.   Farhangi S.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.7, 2003-11, pp. : 2735-2736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation

By Ekberg H.   Backman L.   Tufveson G.   Tyden G.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 267-268

Elsevier

Access to resources Recommend Favorite

Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation

By Vincenti F.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2206-2207

Elsevier

Access to resources Recommend Favorite

Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey

By Waldmann Thomas  

Journal of Clinical Immunology, Vol. 27, Iss. 1, 2007-01 ,pp. : 1-18

Springer Publishing Company

Access to resources Recommend Favorite

Effect of deoxyspergualin on acute and chronic rejection in renal transplantation

By Nomura Y.   Tomikawa S.   Beck Y.   Nishimura Y.   Meigata K.   Ando Y.   Kikuchi K.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3580-3581

Elsevier

Access to resources Recommend Favorite

An Effect of FTY720 on Acute Rejection in Canine Renal Transplantation

By Yuzawa K.   Otsuka M.   Taniguchi H.   Takada Y.   Sakurayama N.   Jinzenji Y.   Suzuki S.   Fukao K.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1046-1046

Elsevier

Access to resources Recommend Favorite